Literature DB >> 15241724

Glucocorticoids and melanocortins in the regulation of body weight in humans.

H L Fehm1, J Born, A Peters.   

Abstract

The last decade witnessed a dramatic increase in knowledge concerning regulation of body weight and obesity. According to recent concepts constancy of body weight is a side product of regulatory events which ensure constant glucose fluxes to the brain. Within these control systems glucocorticoids and melanocortins play a fundamental role at several sites. The melanocortin neurons in the arcuate nucleus are important mediators of the feedback effects of leptin and insulin. Glucocorticoid and mineralocorticoid receptors in hippocampal neurons are crucial as they define the balance between glucose allocation processes and food intake. Thereby, the hippocampal structures determine the setpoint for bodyweight regulation. Novel approaches to treatment of obesity must aim at manipulating these brain structures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241724     DOI: 10.1055/s-2004-814568

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Differential effects of exercise and dietary docosahexaenoic acid on molecular systems associated with control of allostasis in the hypothalamus and hippocampus.

Authors:  F Gomez-Pinilla; Z Ying
Journal:  Neuroscience       Date:  2010-03-18       Impact factor: 3.590

2.  The LIM-homeobox transcription factor Isl1 plays crucial roles in the development of multiple arcuate nucleus neurons.

Authors:  Bora Lee; Seunghee Lee; Soo-Kyung Lee; Jae W Lee
Journal:  Development       Date:  2016-08-30       Impact factor: 6.868

3.  Brain-specific homeobox factor as a target selector for glucocorticoid receptor in energy balance.

Authors:  Bora Lee; Sun-Gyun Kim; Juhee Kim; Kwan Yong Choi; Seunghee Lee; Soo-Kyung Lee; Jae W Lee
Journal:  Mol Cell Biol       Date:  2013-05-13       Impact factor: 4.272

4.  Glucocorticoid effect on insulin sensitivity: a time frame.

Authors:  M Zarkovic; B Beleslin; J Ciric; Z Penezic; M Stojkovic; B Trbojevic; M Drezgic; S Savic
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.